1) Aronson E, Stevenson SB:Bone health in children with cerebral palsy and epilepsy. J Pediatr Health Care 26:193-199, 2012
2) Fehlings D, Switzer L, Agarwal P, et al:Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis:a systematic review. Dev Med Child Neurol 54:106-116, 2012
3) 荻野 浩:重症心身障害児の骨粗鬆症.重症心身障害児の療育5:201-205,2010
4) Halanski M, Noonan KJ:Cast and splint immobilization:complications. J Am Acad Orthop Surg 16:30-40, 2008
5) Henderson RC, Lark RK, Gurka MJ, et al:Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110:1-10, 2002
6) Houlihan CM, Stevenson RD:Bone density in cerebral palsy. Phys Med Rehabil Clin N Am 20:493-508, 2009
7) 稲毛康司:重症心身障害児(者)と骨代謝異常.小児内科33:229-232,2001
8) Iwasaki T, Takei K, Nakamura S, et al:Secondary osteoporosis in long-term bedridden patients with cerebral palsy. Pediatr Int 50:269-275, 2008
9) King W, Levin R, Schmidt R, et al:Prevalence of reduced bone mass in children and adults with spastic quadriplesia. Dev Med Child Neurol 45:12-16, 2003
10) Mergler S, Evenhuis HM, Booy AM, et al:Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy:a systematic review. Dev Med Child Neurol 51:773-778, 2009
11) Paksu MS, Vurucu S, Karaoglu A, et al:Osteopenia in children with cerebral palsy can be treated with oral alendronate. Childs Nerv Syst 28:283-286, 2012
12) Papapoulos SE:Bisphosphonate therapy in children with secondary osteoporosis. Horm Res Paediatr 76:24-27, 2011
13) Presedo A, Dadney KW, Miller F:Fractures in patients with cerebral palsy. J Pediatr Orthop 27:147-153, 2007
14) Sebestyen JF, Srivastava T, Alon US:Bisphosphonates use in children. Clin Pediatr 51:1011-1024, 2012
15) 田中弘之:小児ステロイド性骨粗鬆症.Clin Calcium 19:569-573,2009
16) Ward LM, Petryk A, Gordon CM:Use of bisphosphonates in the treatment of pediadric osteoporosis. Int J Clin Rheumatol 4:657-672, 2009